The Latest Breaking News from Nasdaq

CNBC Ford Motor Selling 8M Shares Of Rivian Automotive

  The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on LogicBio Therapeutics’ (NASDAQ: LOGC) Investigational New Drug Application (IND) of its drug candidate LB-001 for pediatric patients with methylmalonic acidemia.

 

 

 

 

Moderna Inc (NASDAQ: MRNA) is trying to fight off rival companies’ patent infringement claims related to its COVID-19 vaccine, arguing that the companies may only pursue their claims by seeking royalties from the federal government.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes the long-term prospects of Plug Power Inc (NASDAQ: PLUG). "Right now, this is a very tough day for a stock like Plug Power," he added.

BioNTech SE (NASDAQ:BNTX) has reported Q1 FY22 revenues of €6.37 billion compared to €2.05 billion a year ago, mainly due to high demand for the company's COVID-19 vaccine. In Q1 FY22, BioNTech and its partner Pfizer Inc (NYSE:PFE) have invoiced approximately 750 million COVID-19 vaccine doses. As of end-April 2022, the companies have signed orders…

Twenty internet providers agreed to help offer high-speed internet to millions of unconnected households through the bipartisan infrastructure law, the Wall Street Journal reports. The companies included AT&T Inc (NYSE:T), Comcast Corporation (NASDAQ: CMCSA), Verizon Communications Inc (NYSE: VZ), Cox Communications Inc, Charter Communications, Inc (NASDAQ: CHTR), Frontier Communications Parent, Inc (NASDAQ: FYBR) and regional providers like Jackson Energy Authority in Tennessee, Comporium Inc. in…

  Mersana Therapeutics (NASDAQ:MRSN) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.